FRA:FME - Deutsche Boerse Ag - DE0005785802 - Common Stock - Currency: EUR
FRA:FME (4/24/2025, 5:36:15 PM)
42.45
+0.36 (+0.86%)
The current stock price of FME.DE is 42.45 EUR. In the past month the price decreased by -6.5%. In the past year, price increased by 13.44%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CVS.DE | CVS HEALTH CORP | 12.12 | 72.66B | ||
FRE.DE | FRESENIUS SE & CO KGAA | 13.24 | 22.45B | ||
V3V.DE | FAMICORD AG | 29 | 71.62M |
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. The company is headquartered in Bad Homburg Vor Der Hohe, Hessen and currently employs 111,513 full-time employees. The firm provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. The company has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. The company develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The company owns, operates, or manages dialysis clinics sells products to other dialysis providers.
FRESENIUS MEDICAL CARE AG
Else-Kroener-Strasse 1
Bad Homburg vor der Hohe HESSEN DE
Employees: 113639
Company Website: https://www.freseniusmedicalcare.com/
Investor Relations: https://www.freseniusmedicalcare.com/en/investors/investors-overview/
Phone: 4961726090
The current stock price of FME.DE is 42.45 EUR. The price increased by 0.86% in the last trading session.
The exchange symbol of FRESENIUS MEDICAL CARE AG is FME and it is listed on the Deutsche Boerse Ag exchange.
FME.DE stock is listed on the Deutsche Boerse Ag exchange.
26 analysts have analysed FME.DE and the average price target is 48.09 EUR. This implies a price increase of 13.28% is expected in the next year compared to the current price of 42.45. Check the FRESENIUS MEDICAL CARE AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.
FRESENIUS MEDICAL CARE AG (FME.DE) has a market capitalization of 24.91B EUR. This makes FME.DE a Large Cap stock.
FRESENIUS MEDICAL CARE AG (FME.DE) currently has 113639 employees.
FRESENIUS MEDICAL CARE AG (FME.DE) has a support level at 41.55 and a resistance level at 43.16. Check the full technical report for a detailed analysis of FME.DE support and resistance levels.
The Revenue of FRESENIUS MEDICAL CARE AG (FME.DE) is expected to grow by 4.49% in the next year. Check the estimates tab for more information on the FME.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
FRESENIUS MEDICAL CARE AG (FME.DE) has a dividend yield of 3.46%. The yearly dividend amount is currently 1.19. Check the full fundamental report for a detailed analysis of FME.DE dividend history, reliability and sustainability.
FRESENIUS MEDICAL CARE AG (FME.DE) will report earnings on 2025-05-06.
The PE ratio for FRESENIUS MEDICAL CARE AG (FME.DE) is 13.06. This is based on the reported non-GAAP earnings per share of 3.25 and the current share price of 42.45 EUR. Check the full fundamental report for a full analysis of the valuation metrics for FME.DE.
ChartMill assigns a technical rating of 1 / 10 to FME.DE. When comparing the yearly performance of all stocks, FME.DE is one of the better performing stocks in the market, outperforming 70.03% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to FME.DE. FME.DE has only an average score on both its financial health and profitability.
Over the last trailing twelve months FME.DE reported a non-GAAP Earnings per Share(EPS) of 3.25. The EPS increased by 26.66% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 2.78% | ||
ROA | 1.6% | ||
ROE | 3.69% | ||
Debt/Equity | 0.67 |
ChartMill assigns a Buy % Consensus number of 66% to FME.DE. The Buy consensus is the average rating of analysts ratings from 26 analysts.
For the next year, analysts expect an EPS growth of 14.02% and a revenue growth 4.49% for FME.DE